Published on 21 Mar 2024 on Simply Wall St. via Yahoo Finance
Potential Immuneering Corporation (NASDAQ:IMRX) shareholders may wish to note that the Director, Peter Feinberg, recently bought US$183k worth of stock, paying US$2.44 for each share. Although the purchase only increased their holding by 7.5%, it is still a solid purchase in our view.
Check out our latest analysis for Immuneering
The Last 12 Months Of Insider Transactions At Immuneering